Nanoregulation: A recent scare involving nanotech products reveals that the technology is not yet properly regulated

EMBO Reports

Volumn 7, Issue 9, 2006, Pages 858-861

  Wolinsky, Howard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; TOXIC SUBSTANCE;

AEROSOL; ARTICLE; CONSUMER; COUGHING; ENVIRONMENTAL HEALTH; EUROPEAN UNION; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEADACHE; HEALTH HAZARD; HUMAN; LAW; LUNG EDEMA; NANOTECHNOLOGY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP DISORDER; SYMPTOM; VOMITING;

BIOTECHNOLOGY; DRUG UTILIZATION; GOVERNMENT REGULATION; NANOTECHNOLOGY; QUALITY CONTROL; TECHNOLOGY;

EID: 33749519060     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400799     Document Type: Article

References (5)

1. Davies JC (2006) Managing the Effects of Nanotechnology. Washington, DC, USA: Project on Emerging Nanotechnologies
2. ETC Group (2003) The Big Down: Atomtech-Technologies Converging at the Nano-scale. Ottawa, ON, Canada: ETC Group. www.etcgroup.org
3. International Center for Technology Assessment (2006) Citizen Petition to the United States Food and Drug Administration: Petition requesting FDA amend its regulations for products composed of engineered nanoparticles generally and sunscreen drug products composed of engineered nanoparticles specifically. Washington, DC, USA: International Center for Technology Assessment. www.icta.org
4. The Royal Society, The Royal Academy of Engineering (2004) Nanoscience and Nanotechnologies: Opportunities and Uncertainties. Summary document. London, UK: The Royal Society
5. SCENIHR (2006) Modified opinion (after publish consultation) on the appropriateness of existing technologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. SCENIHR/002/05. Brussels, Belgium: Scientific Committee on Emerging and Newly Identified Health Risks